Cargando…
Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study
BACKGROUND: Cardiovascular disease (CVD) is a leading cause of death among adults with type 2 diabetes mellitus (T2D). We recently reported that glycemic control in patients with T2D can be significantly improved through a continuous care intervention (CCI) including nutritional ketosis. The purpose...
Autores principales: | Bhanpuri, Nasir H., Hallberg, Sarah J., Williams, Paul T., McKenzie, Amy L., Ballard, Kevin D., Campbell, Wayne W., McCarter, James P., Phinney, Stephen D., Volek, Jeff S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928595/ https://www.ncbi.nlm.nih.gov/pubmed/29712560 http://dx.doi.org/10.1186/s12933-018-0698-8 |
Ejemplares similares
-
Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial
por: Athinarayanan, Shaminie J., et al.
Publicado: (2019) -
SUN-LB113 A Continuous Remote Care Intervention Utilizing Carbohydrate Restriction Including Nutritional Ketosis Improves Markers of Metabolic Risk and Reduces Diabetes Medication Use in Patients With Type 2 Diabetes Over 3.5 Years
por: McKenzie, Amy, et al.
Publicado: (2020) -
Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study
por: Hallberg, Sarah J., et al.
Publicado: (2018) -
Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study
por: Hallberg, Sarah J., et al.
Publicado: (2018) -
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study
por: Vilar-Gomez, Eduardo, et al.
Publicado: (2019)